Baxter Issues Spectrum Infusion Pump Safety Alert After 3 Patient Deaths
Executive Summary
The urgent safety communication says the company has been notified about 51 serious injuries and three deaths related to issues with the pumps’ upstream occlusion alarms.
You may also be interested in...
Baxter Wins 510(k) Clearance For New Infusion Pump With Safety Software
The US FDA has granted Baxter International 510(k) clearance for its new Novum IQ syringe infusion pump with safety hardware. The approval opens a new market opportunity for the company.
Baxter’s Recall Of Spectrum Infusion Pumps Given Class I Label By FDA
The US agency said the device maker initiated the recall in December because the pumps might not alarm for repeated occlusion events.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.